In contrast, METTL3 knockout accelerates pathological cardiac hypertrophy and heart failure by reducing m6A levels of poly (ADP-ribose) polymerase family member 10 (Parp10) mRNA and increasing PARP10 expression [117, 118]. Here, METTL3 is linked to cardiac hypertrophy.